Krilogy Financial’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Krilogy Financial’s Portfolio IBDS Stock Details IBDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.29M	Sell	218,269 -4,666	-2%	-$113K	0.16%	106
2026 Q1	$5.4M	Buy	222,935 +1,829	+0.8%	+$44.4K	0.17%	98
2025 Q4	$5.38M	Buy	221,106 +7,201	+3%	+$175K	0.18%	88
2025 Q3	$5.18M	Buy	213,905 +25,297	+13%	+$613K	0.19%	82
2025 Q2	$4.58M	Buy	188,608 +31,632	+20%	+$763K	0.26%	78
2025 Q1	$3.8M	Buy	156,976 +4,620	+3%	+$111K	0.25%	85
2024 Q4	$3.65M	Buy	152,356 +14,364	+10%	+$346K	0.24%	85
2024 Q3	$3.36M	Sell	137,992 -24,551	-15%	-$592K	0.23%	97
2024 Q2	$3.86M	Buy	162,543 +1,274	+0.8%	+$30.1K	0.28%	79
2024 Q1	$3.84M	Buy	161,269 +4,360	+3%	+$104K	0.29%	79
2023 Q4	$3.75M	Buy	156,909 +5,463	+4%	+$127K	0.32%	73
2023 Q3	$3.5M	Buy	151,446 +1,336	+0.9%	+$31.2K	0.32%	73
2023 Q2	$3.52M	Buy	150,110 +880	+0.6%	+$20.8K	0.32%	76
2023 Q1	$3.55M	Buy	149,230 +88,158	+144%	+$2.08M	0.3%	76
2022 Q4	$1.43M	Sell	61,072 -76,009	-55%	-$1.76M	0.14%	122
2022 Q3	$3.15M	Sell	137,081 -18	-0%	-$430	0.38%	44
2022 Q2	$3.27M	Buy	137,099 +49,764	+57%	+$1.2M	0.38%	44
2022 Q1	$2.18M	Sell	87,335 -61,734	-41%	-$1.58M	0.22%	69
2021 Q4	$3.96M	Buy	149,069 +557	+0.4%	+$14.8K	0.4%	45
2021 Q3	$4.01M	Buy	148,512 +3,308	+2%	+$89.8K	0.4%	44
2021 Q2	$3.93M	Buy	145,204 +14,488	+11%	+$390K	0.39%	44
2021 Q1	$3.49M	Buy	130,716 +33,538	+35%	+$913K	0.37%	45
2020 Q4	$2.68M	Buy	97,178 +898	+0.9%	+$24.5K	0.32%	50
2020 Q3	$2.61M	Sell	96,280 -21,642	-18%	-$589K	0.36%	49
2020 Q2	$3.18M	Buy	117,922 +52,823	+81%	+$1.37M	0.49%	32
2020 Q1	$1.6M	Sell	65,099 -50,398	-44%	-$1.3M	0.3%	52
2019 Q4	$3M	Sell	115,497 -833	-0.7%	-$21.6K	0.49%	41
2019 Q3	$3.02M	Sell	116,330 -4,353	-4%	-$112K	0.54%	42
2019 Q2	$3.08M	Buy	120,683 +12,744	+12%	+$315K	0.59%	28
2019 Q1	$2.65M	Buy	+107,939	New	+$2.58M	0.56%	32

Other funds holding IBDS

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SVWAG

Sound View Wealth Advisors Group Savannah, Georgia $1.61B AUM 26.11% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Krilogy Financial's IBDS Position: Q2 2026 in Review

Krilogy Financial reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 2.1% in Q2 2026, selling an estimated $113K and leaving 218,269 shares worth $5.29M. The position accounts for 0.16% of the portfolio, ranked #106.

Krilogy Financial first reported a position in IBDS in Q1 2019 and has held it in 30 quarters since. The position peaked at $5.4M in Q1 2026. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

Krilogy Financial held 218,269 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $5.29M as of Q2 2026.
Krilogy Financial sold 4,666 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $113K.
iShares iBonds Dec 2027 Term Corporate ETF made up 0.16% of Krilogy Financial's portfolio in Q2 2026, its #106 holding.
Krilogy Financial first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2019 and has held it in 30 quarters since.
Krilogy Financial's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $5.4M in Q1 2026.
416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.